How High Will Eli Lilly Stock Go By 2030?
The weight loss drugs market is heating up quickly and…
Sell
33
LMND Quote, Financials, Valuation and Earnings
Last price:
$27.30
Seasonality move
:
12.22%
Day range:
$25.07 - $26.60
52-week range:
$14.03 - $53.85
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
3.47x
P/B ratio:
3.16x
Volume:
933K
Avg. volume:
1.8M
1-year change:
62.23%
Market cap:
$1.9B
Revenue:
$526.5M
EPS (TTM):
-$2.84
Earnings Data
Next earnings date for LMND
Apr 30
2025
Most recent earnings per share
-$0.41
Beat by $0.15
(Feb 25/2025)
Consensus Estimate
-$0.56
(Feb 25/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
LMND Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 06/30/2025 | Q2 | $158.2M | -- | -- | -$0.71 | -- |
| 04/30/2025 | Q1 | $145M | -- | -- | -$0.84 | -- |
| 02/25/2025 | Q4 | $144.8M | $148.8M | -$0.41 | -$0.56 | $0.15 |
| 10/30/2024 | Q3 | $126.5M | $136.6M | -$0.95 | -$0.91 | -$0.04 |
| 07/30/2024 | Q2 | $121.4M | $122M | -$0.81 | -$0.87 | $0.06 |
| 04/30/2024 | Q1 | $113.4M | $119.1M | -$0.67 | -$0.72 | $0.05 |
| 02/27/2024 | Q4 | $111.5M | $115.5M | -$0.60 | -$0.75 | $0.15 |
| 11/01/2023 | Q3 | $104.5M | $114.5M | -$0.88 | -$0.84 | -$0.04 |
| 08/02/2023 | Q2 | $97.6M | $104.6M | -$0.97 | -$1.00 | $0.03 |
| 05/03/2023 | Q1 | $88.2M | $95.2M | -$0.95 | -$1.09 | $0.14 |
| 02/22/2023 | Q4 | -- | $88.4M | -$0.90 | -- | -- |
| 11/08/2022 | Q3 | -- | $74M | -$1.37 | -- | -- |
| 08/08/2022 | Q2 | -- | $50M | -$1.10 | -- | -- |
| 05/09/2022 | Q1 | -- | $44.3M | -$1.21 | -- | -- |
| 02/23/2022 | Q4 | -- | $41M | -$1.14 | -- | -- |
| 11/08/2021 | Q3 | -- | $35.7M | -$1.08 | -- | -- |
| 08/04/2021 | Q2 | -- | $28.2M | -$0.90 | -- | -- |
| 05/11/2021 | Q1 | -- | $23.5M | -$0.81 | -- | -- |
| 03/01/2021 | Q4 | -- | $20.5M | -$0.60 | -- | -- |
| 11/11/2020 | Q3 | -- | $17.8M | -$0.57 | -- | -- |
| 08/12/2020 | Q2 | -- | $29.9M | -$0.38 | -- | -- |
| 03/31/2020 | Q1 | -- | $26.2M | -$0.66 | -- | -- |
| 12/31/2019 | Q4 | -- | $23.6M | -$0.75 | -- | -- |
| 09/30/2019 | Q3 | -- | $18.9M | -$0.71 | -- | -- |
| 06/30/2019 | Q2 | -- | $13.8M | -$0.53 | -- | -- |
| 03/31/2019 | Q1 | -- | $11M | -$0.50 | -- | -- |
Lemonade Earnings Questions
-
How Much did Lemonade Generate in Revenue Last Quarter?
Lemonade reported $148.8M worth of top line sales in its most recent quarter.
-
Did Lemonade Beat Earnings Last Quarter?
Lemonade announced earnings per share of -$0.41 which represents a beat of analyst forecast a -$0.56 per share.
-
Is Lemonade Profitable?
Lemonade reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for Lemonade EPS Next Year?
Lemonade's earnings are forecast to decrease from -$2.85 per share to -$2.98 per share next year representing a decrease of -1.05%.
-
When is Lemonade's Earnings Date?
Lemonade's next earnings date is April 30, 2025.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is TSMC the Best Semiconductor Stock to Buy Now?
The new administration has launched a slew of tariffs, paused…
Rocket Lab Vs Intuitive Machines Stock
The commercialization of outer space is now in full swing,…
Stock Ideas
Sell
48
Is AAPL Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 32x
Sell
43
Is MSFT Stock a Buy?
Market Cap: $2.7T
P/E Ratio: 30x
Sell
40
Is NVDA Stock a Buy?
Market Cap: $2.4T
P/E Ratio: 33x
Alerts
Buy
58
AGX alert for Apr 22
Argan [AGX] is up 3.08% over the past day.
Sell
44
INOD alert for Apr 22
Innodata [INOD] is up 5.26% over the past day.
Sell
44
UHS alert for Apr 22
Universal Health Services [UHS] is up 2.73% over the past day.
